|
The Preliminary Study of Methotrexate Encapsulated Reverse Micelles preparation for Psoriasis Treatment |
|---|---|
| รหัสดีโอไอ | |
| Creator | Pathomthat Srisuk |
| Title | The Preliminary Study of Methotrexate Encapsulated Reverse Micelles preparation for Psoriasis Treatment |
| Contributor | Seangrawee Sutoarinyanan, Padungkwan Chitropas, Watcharee Khunkitti |
| Publisher | Faculty of Pharmaceutical Sciences KKU MSU UBU |
| Publication Year | 2561 |
| Journal Title | Isan Journal of Pharmaceutical Sciences |
| Journal Vol. | 14 |
| Journal No. | 1 |
| Page no. | 35-44 |
| Keyword | reverse micelles, methotrexate, chitosan, psoriasis, topical drug delivery systems |
| URL Website | https://tci-thaijo.org/index.php/IJPS |
| Website title | Isan Journal ofPharmaceutical Sciences, IJPS |
| ISSN | 19050852 |
| Abstract | Introduction: Methotrexate (MTX) is commonly used in severe psoriasis treatment but major side effects such as hepatoxicity and bone marrow suppression are mainly limited its use. To avoid these problems, localized topical delivery has been initiated to prepare using a reverse micelle system (RMs) that consisted of sodium bis (ethyl hexyl) sulfosuccinate (AOT) as a surfactant, n-hexane as a solvent, glutaraldehyde (GTA) as a crosslinking agent, and chitosan (CS) as core-shell. Methods: The aim of the study is to investigate the effect of different molecular weights (MWs) of CS on the physical properties; mean diameter, zeta potential, and MTX encapsulation efficiency (%EE). All RMs formulations were physically characterized by dynamic light scattering (DLS) and UV-Vis spectroscopy. Results: Results reveal that the mean diameter of the prepared RMs with different MWs of CS was in averaged range of 400-900 nm. The zeta potential and %EE were approximately -60 to -30 mV and 90%. In view of the experiment, the MWs of CS is a major parameter affecting to the mean diameter of RMs. In contrary, CaCl2 has the smallest effect on the particle size of RMs. Conclusion: High encapsulation of MTX in RMs can suggest that further develop to be a potential carrier in topical delivery system and MTX loaded RMs might reduce its side effects and improves its therapeutic efficacy in the treatment of psoriasis. |
